These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10417623)

  • 1. Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes.
    Santamaria LF; Torres R; Giménez-Arnau AM; Giménez-Camarasa JM; Ryder H; Palacios JM; Beleta J
    J Invest Dermatol; 1999 Jul; 113(1):82-6. PubMed ID: 10417623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production.
    Leung DY; Gately M; Trumble A; Ferguson-Darnell B; Schlievert PM; Picker LJ
    J Exp Med; 1995 Feb; 181(2):747-53. PubMed ID: 7836926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
    Teraki Y; Hotta T; Shiohara T
    J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rolipram inhibits polarization and migration of human T lymphocytes.
    Layseca-Espinosa E; Baranda L; Alvarado-Sánchez B; Portales-Pérez D; Portillo-Salazar H; González-Amaro R
    J Invest Dermatol; 2003 Jul; 121(1):81-7. PubMed ID: 12839567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.
    Meskini N; Hosni M; Nemoz G; Lagarde M; Prigent AF
    J Cell Physiol; 1992 Jan; 150(1):140-8. PubMed ID: 1309823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
    Coqueret O; Boichot E; Lagente V
    Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
    Beshay E; Croze F; Prud'homme GJ
    Clin Immunol; 2001 Feb; 98(2):272-9. PubMed ID: 11161985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression.
    Essayan DM; Huang SK; Kagey-Sobotka A; Lichtenstein LM
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):28-37. PubMed ID: 9003208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.
    Akdis M; Simon HU; Weigl L; Kreyden O; Blaser K; Akdis CA
    J Immunol; 1999 Jul; 163(1):466-75. PubMed ID: 10384150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
    Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
    J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lymphocyte antigen expression on activated lymphocytes and its association with IL-12R (beta1 and beta2), IL-2Ralpha, and CXCR3.
    Reddy M; Davis C; Wong J; Prabhakar U
    Cell Immunol; 2005; 236(1-2):131-9. PubMed ID: 16165116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy.
    Piletta PA; Wirth S; Hommel L; Saurat JH; Hauser C
    Arch Dermatol; 1996 Oct; 132(10):1171-6. PubMed ID: 8859027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CLA+ lymphocytes from children with atopic dermatitis contain an increased percentage of cells bearing staphylococcal-related T-cell receptor variable segments.
    Torres MJ; Gonzalez FJ; Corzo JL; Giron MD; Carvajal MJ; Garcia V; Pinedo A; Martinez-Valverde A; Blanca M; Santamaria LF
    Clin Exp Allergy; 1998 Oct; 28(10):1264-72. PubMed ID: 9824394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 alone can not enhance the expression of the cutaneous lymphocyte associated antigen (CLA) by superantigen-stimulated T lymphocytes.
    Sigmundsdóttir H; Gudjónsson JE; Valdimarsson H
    Clin Exp Immunol; 2003 Jun; 132(3):430-5. PubMed ID: 12780689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.
    Barnette MS; Christensen SB; Essayan DM; Grous M; Prabhakar U; Rush JA; Kagey-Sobotka A; Torphy TJ
    J Pharmacol Exp Ther; 1998 Jan; 284(1):420-6. PubMed ID: 9435206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.